BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 18, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ACU-4429: Phase II started

Acucela began the double-blind, dose-escalation, U.S. Phase II ENVISION Clarity trial to compare 5, 10 or 20 mg oral ACU-4429 vs....

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >